Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of AnaptysBio Inc (NASDAQ: ANAB) was $22.2 for the day, down -1.20% from the previous closing price of $22.47. In other words, the price has decreased by -$1.20 from its previous closing price. On the day, 0.53 million shares were traded. ANAB stock price reached its highest trading level at $22.83 during the session, while it also had its lowest trading level at $21.98.
Ratios:
Our analysis of ANAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.25 and its Current Ratio is at 8.25. In the meantime, Its Debt-to-Equity ratio is 10.17 whereas as Long-Term Debt/Eq ratio is at 10.11.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $25.
H.C. Wainwright Downgraded its Buy to Neutral on December 11, 2024, whereas the target price for the stock was revised from $52 to $19.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 18 ’25 when FENTON DENNIS M sold 3,015 shares for $23.97 per share. The transaction valued at 72,270 led to the insider holds 4,965 shares of the business.
RENTON HOLLINGS sold 3,015 shares of ANAB for $72,270 on Jun 18 ’25. The Director now owns 4,965 shares after completing the transaction at $23.97 per share. On Jun 18 ’25, another insider, HOLLINGS C RENTON, who serves as the Director of the company, bought 3,015 shares for $23.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 652247104 and an Enterprise Value of 658268032. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.83 while its Price-to-Book (P/B) ratio in mrq is 19.83. Its current Enterprise Value per Revenue stands at 5.884 whereas that against EBITDA is -6.603.
Stock Price History:
The Beta on a monthly basis for ANAB is -0.27, which has changed by -0.072681725 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $12.21. The 50-Day Moving Average of the stock is 2.54%, while the 200-Day Moving Average is calculated to be 2.01%.
Shares Statistics:
ANAB traded an average of 664.38K shares per day over the past three months and 482450 shares per day over the past ten days. A total of 30.39M shares are outstanding, with a floating share count of 26.44M. Insiders hold about 10.01% of the company’s shares, while institutions hold 128.18% stake in the company. Shares short for ANAB as of 1749772800 were 9153626 with a Short Ratio of 13.78, compared to 1747267200 on 8831692. Therefore, it implies a Short% of Shares Outstanding of 9153626 and a Short% of Float of 56.229997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
